Article Figures & Tables
Figures
- Figure 1:
Expenditure per capita on prescription drugs from 1985 to 2016 in Quebec and the rest of Canada, (A) tax-financed versus (B) household- and employer-financed. Source: Authors’ calculations-based data from Canadian Institute for Health Information National Health Expenditure Trends, 1975 to 2016.23 Tax-financed expenditures are those paid through government general revenues; household- and employer-financed expenditures are those paid out of pocket or through premium contributions to mandatory private or public insurance plans. Quebec data for 2015 and 2016 projected based on five-year average growth rates.
Tables
- Table 1:
Cost-related nonadherence to prescription drugs, total out-of-pocket payments and total pharmaceutical expenditure per capita for Canada, Quebec and 9 comparable high-income countries with universal health insurance*
Jurisdiction Cost-related nonadherence: % of adult population reporting they did not fill a prescription or skipped doses because of the cost in 2016 Out-of-pocket costs: % of adult population reporting their household spent $1000 or more in out-of-pocket costs in 2007 Total pharmaceutical expenditure per capita in 2014, Canadian dollars (purchasing power parity), $ Quebec 8.8 8.7 1087 Rest of Canada 10.7 4.8 912 Population-weighted average for Canada 10.2 5.7 952 Australia 6.3 5.3 753† New Zealand 5.7 2.4 369‡ Norway 3.4 – 564 Sweden 5.7 – 603 United Kingdom 2.1 1.2 598 Population-weighted average for universal public systems 3.6 – 621 France 3.9 – 809 Germany 3.2 2.8 900 Netherlands 4.4 0.9 494 Switzerland 8.9 – 914 Population-weighted average for social insurance systems 3.8 – 826 ↵* Authors’ calculations based on the Commonwealth Fund’s 2016 International Health Policy Survey; the Commonwealth Fund’s 2007 International Health Policy Survey; Statistics Canada’s 2007 Survey of Household Spending; and the Organisation for Economic Co-operation and Development’s Health Data 2016 data sets.13–15
↵† Projected from 2013 based on growth rates in other comparator countries.
↵‡ Projected from 2007 based on growth rates in other comparator countries.
In this issue
Article tools
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Collections
